Strumento inattivo

Azioni Islet Sciences Inc OTC Bulletin Board

Azioni

Prezzo di chiusura OTC Bulletin Board Altri mercati azionari
- ^USD	-

Islet Sciences, Inc. Publishes Data Supporting Remogliflozin Etabonate as a Potential Treatment for NAFLD and NASH	04/05/15
Islet Sciences, Inc. Presented at 50th International Liver Conference	23/04/15
Islet Sciences, Inc. COO to Present at Metabolic Leaders Forum	24/03/15
Islet Sciences, Inc. COO to Present at EASL: Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)	09/03/15
Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD	05/03/15

Settore

	Variaz. 1 gen.	Capi.
MODERNA, INC.	+41,79%	50,93 Mrd
IQVIA HOLDINGS INC.	-0,56%	42,12 Mrd
LONZA GROUP AG	+49,62%	42,05 Mrd
CELLTRION, INC.	-7,20%	29,18 Mrd
ICON PUBLIC LIMITED COMPANY	+12,59%	26,02 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-21,51%	18,9 Mrd
BIO-TECHNE CORPORATION	+6,92%	13,21 Mrd
UNITED THERAPEUTICS CORPORATION	+24,91%	12,17 Mrd
MEDPACE HOLDINGS, INC.	+29,60%	12,16 Mrd